The Global Antibiotic Research and Development Partnership (GARDP) in collaboration with the TB Alliance organise a live webinar :
Discovering and developing
new treatments for tuberculosis
24 March 2021
Registration is free of charge on the website dedicated to the symposium.
GARDP is a not-for-profit organization focused on developing new treatments for drug-resistant infections that pose the greatest threat to health, and ensuring access to affordable and effective antibiotic treatment globaly. GARDP aims to develop five new treatments by 2025 to fight drug-resistant infections, focusing on sexually transmitted infections, sepsis in newborns and infections in hospitalized adults and children.
Speaker: Nader Fotouhi, Chief Scientific Officer, TB Alliance (US)
Moderator: Lydia Nakiyingi, infectious diseases physician, research scientist and senior lecturer, Makerere University College of Health Sciences (Uganda)
Nader’s presentation will discuss:
- 20 Years of Impact: Introduction to TB Alliance and an overview of TB drug development in the 21st century
- The TB drug discovery and development landscape today: state of the global pipeline and survey of TB Alliance’s programs
- Case study: a new therapy for highly drug-resistant forms of TB
- Where do we go from here? New partnerships and new treatment paradigms to reimagine TB treatment
The presentation will be followed by a Q&A session.
This live webinar including interactive Q&A session will be broadcast on 24 March 2021 at 14:30-16:00 CET. Find your time zone here.
If you have questions or comments, please let us know: email@example.com.